“…Many clinical applications have been investigated by this method, including biomarker identification of breast cancer (Thakur et al, 2011;Zanni and Chan, 2011;Zhang et al, 2005), pancreatic ductal carcinoma (Shekouh et al, 2003), nasopharyngeal carcinoma (Cheng et al, 2008), hepatocellular carcinoma (Wong and Luk, 2012), and abdominal aortic aneurysms (Boytard et al, 2013). In this last study, Boytard and colleagues highlighted that CD68( + )MR(-) macrophages could contribute to aneurysmal pathology, on the basis of the analyses of 2DE separated proteins originated from different types of macrophages.…”